Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) Free cash flow

Alert me on Free cash flow

Revvity Inc.'s free cash flow for fiscal 2025 was $509.4M, down 5.95% from $541.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was $570.2M. Over the past ten years it has ranged from $9.9M (fiscal 2023) to $1.3B (fiscal 2021); the current reading is higher than 64% of that period. Revvity Inc. ranks 12th of 52 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $509.4M (5.95%)
FY2024 $541.7M 5,369.01%
FY2023 $9.9M (98.33%)
FY2022 $594.2M (55.15%)
FY2021 $1.3B 59.07%
FY2020 $832.8M 194.61%
FY2019 $282.7M 10.51%
FY2018 $255.8M 2.14%
FY2017 $250.5M (26.32%)
FY2016 $339.9M 31.30%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $183.9M 76.06%
Mar 2026 $104.5M (35.44%)
Dec 2025 $161.8M 34.83%
Sep 2025 $120.0M 3.94%
42 more quarters

Against its own ten years

Low $9.9M High $1.3B
Ten-year median $339.9M
Current reading's percentile 64

Free cash flow against peers

Company Free cash flow
DGX Quest Diagnostics Incorporated compare $1.3B
LH Labcorp Holdings Inc. compare $1.2B
ICLR ICON PLC compare $883.8M
MEDP Medpace Holdings, Inc. compare $706.7M
RVTY Revvity Inc. $570.2M
QGEN QIAGEN N.V. compare $440.6M
CRL Charles River Laboratories International, Inc. compare $370.6M
TWST Twist Bioscience Corporation compare −$95.6M
GH Guardant Health, Inc. compare −$240.7M

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on RVTY